2023
DOI: 10.14202/vetworld.2023.618-630
|View full text |Cite
|
Sign up to set email alerts
|

First study on in vitro antiviral and virucidal effects of flavonoids against feline infectious peritonitis virus at the early stage of infection

Abstract: Background and Aim: Feline infectious peritonitis (FIP), one of the most important infectious diseases in cats is caused by FIP virus (FIPV), a mutated variant of feline coronavirus. Feline infectious peritonitis has a negative impact on feline health, with extremely high mortality in clinical FIP-infected cats, particularly young cats. There are no approved drugs for FIP treatment, and therapeutic possibilities for FIP treatment are limited. This study aimed to utilize nature-derived bioactive flavonoids with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 52 publications
1
2
0
Order By: Relevance
“…This observation aligns with the characteristics of other flavonoids, such as isoginkgetin and luteolin, which have been reported to inhibit FIPV in the early replication stages but do not block virus entry (Triratapiban et al. 2023 ).…”
Section: Discussionsupporting
confidence: 89%
“…This observation aligns with the characteristics of other flavonoids, such as isoginkgetin and luteolin, which have been reported to inhibit FIPV in the early replication stages but do not block virus entry (Triratapiban et al. 2023 ).…”
Section: Discussionsupporting
confidence: 89%
“…10.1.10. Miscellaneous Antiviral Treatments Some other drugs have only been investigated in vitro, and in vivo efficacy is unknown, such as vidarabine [359], which inhibits polymerase activity; nelfinavir, a commercially available protease inhibitor of human immunodeficiency virus [355]; Galanthus nivalis agglutinin, a carbohydrate-binding agent that binds to FCoV-glycosylated envelope glycoproteins, thereby inhibiting viral attachment to the host cell [355,392]; K31, a novel compound that binds and alters the conformation of the FCoV nucleocapsid protein [393]; plant-derived flavonoids (including isoginkgetin) [394]; and ERDRP-0516, a non-nucleoside inhibitor of the RNA-dependent RNA polymerase [395]. One study has shown evidence of antiviral synergy between GS-441524 and itraconazole in vitro, especially against a type I FCoV [352].…”
Section: Cyclosporine Amentioning
confidence: 99%
“…A recent study has highlighted the antiviral activity of an extract from the d3 Chinese herb against FIPV, suggesting a promising avenue for natural component-based therapies (Nishijıma et al, 2023). Furthermore, flavonoids such as isoginkgetin and luteolin have been found to inhibit FIPV replication and exhibit virucidal effects, providing a foundation for the development of flavonoid-based antiviral drugs (Triratapiban et al, 2023).…”
Section: Introductionmentioning
confidence: 99%